| 000 | 01751 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250518080832.0 | ||
| 264 | 0 | _c20210405 | |
| 008 | 202104s 0 0 eng d | ||
| 022 | _a1878-5506 | ||
| 024 | 7 |
_a10.1016/j.sleep.2019.11.1250 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEmsellem, Helene A | |
| 245 | 0 | 0 |
_aMeasures of functional outcomes, work productivity, and quality of life from a randomized, phase 3 study of solriamfetol in participants with narcolepsy. _h[electronic resource] |
| 260 |
_bSleep medicine _c03 2020 |
||
| 300 |
_a128-136 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCarbamates _xtherapeutic use |
| 650 | 0 | 4 | _aDisorders of Excessive Somnolence |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aEfficiency |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNarcolepsy _xcomplications |
| 650 | 0 | 4 |
_aPhenylalanine _xanalogs & derivatives |
| 650 | 0 | 4 | _aPhysical Functional Performance |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 |
_aWakefulness _xdrug effects |
| 700 | 1 | _aThorpy, Michael J | |
| 700 | 1 | _aLammers, Gert Jan | |
| 700 | 1 | _aShapiro, Colin M | |
| 700 | 1 | _aMayer, Geert | |
| 700 | 1 | _aPlazzi, Giuseppe | |
| 700 | 1 | _aChen, Dan | |
| 700 | 1 | _aCarter, Lawrence P | |
| 700 | 1 | _aVilla, Kathleen F | |
| 700 | 1 | _aLee, Lawrence | |
| 700 | 1 | _aMenno, Diane | |
| 700 | 1 | _aBlack, Jed | |
| 700 | 1 | _aDauvilliers, Yves | |
| 773 | 0 |
_tSleep medicine _gvol. 67 _gp. 128-136 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.sleep.2019.11.1250 _zAvailable from publisher's website |
| 999 |
_c30507528 _d30507528 |
||